ESMO shared on LinkedIn:
“For ESMO members: Breaking Science in Gastrointestinal Cancers.
Kohei Shitara talks about the Perioperative pembrolizumab plus chemotherapy in locally-advanced gastric/GEJ cancer.
Full interview available now on OncologyPRO.”
Proceed to the video attached to the post.
Source: ESMO/LinkedIn